2017 Versus 2012 Appropriate Use Criteria for Percutaneous Coronary Interventions: Impact on Appropriateness Ratings

Edward L. Hannan, Zaza Samadashvili, Kimberly Cozzens, Peter B. Berger, Joanna Chikwe, Alice K. Jacobs, Gary D Walford, Frederick S.K. Ling, Ferdinand J. Venditti, Jeffrey Gold, Spencer B. King

Research output: Contribution to journalArticle

Abstract

Objectives: The purpose of this study is to revisit cases rated as “inappropriate” in the 2012 appropriate use criteria (AUC) using the 2017 AUC. Background: AUC for coronary revascularization in patients with stable ischemic heart disease (SIHD) were released in January 2017. Earlier 2012 AUC identified a relatively high percentage of New York State patients for whom percutaneous coronary intervention (PCI) was rated as “inappropriate” versus optimal medical therapy alone. Methods: New York State's PCI registry was used to rate inappropriateness of patients undergoing PCI in 2014 using the 2012 and 2017 AUC, and to examine patient characteristics for patients rated differently. Results: A total of 911 of 9,261 (9.8%) patients who underwent PCI in New York State in 2014 with SIHD without prior coronary artery bypass grafting were rated as “inappropriate” using the 2012 AUC, but only 171 (1.8%) patients were rated as “rarely appropriate” (“inappropriate” in 2012 AUC terminology) using the 2017 AUC. A total of 26% of all 8,407 patients undergoing PCI in New York State with 1- to 2-vessel SIHD were without high-risk findings on noninvasive testing and were either asymptomatic or without antianginal therapy. No current or past randomized controlled trials have focused on these patients. Conclusions: The percentage of 2014 New York State PCI patients with SIHD who are rated “rarely appropriate” has decreased substantially using 2017 AUC in comparison with the older 2012 AUC. However, for many low-risk patients undergoing the procedure, the relative benefits of optimal medical therapy with and without PCI are unknown. Randomized controlled trials are needed to study these groups.

LanguageEnglish (US)
Pages500-502
Number of pages3
JournalJACC: Cardiovascular Interventions
Volume11
Issue number5
DOIs
StatePublished - Mar 12 2018

Fingerprint

Percutaneous Coronary Intervention
Myocardial Ischemia
Randomized Controlled Trials
Terminology
Coronary Artery Bypass
Registries
Therapeutics

Keywords

  • AUC
  • coronary revascularization appropriateness
  • percutaneous coronary intervention
  • stable ischemic heart disease

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Hannan, E. L., Samadashvili, Z., Cozzens, K., Berger, P. B., Chikwe, J., Jacobs, A. K., ... King, S. B. (2018). 2017 Versus 2012 Appropriate Use Criteria for Percutaneous Coronary Interventions: Impact on Appropriateness Ratings. JACC: Cardiovascular Interventions, 11(5), 500-502. https://doi.org/10.1016/j.jcin.2018.01.235

2017 Versus 2012 Appropriate Use Criteria for Percutaneous Coronary Interventions : Impact on Appropriateness Ratings. / Hannan, Edward L.; Samadashvili, Zaza; Cozzens, Kimberly; Berger, Peter B.; Chikwe, Joanna; Jacobs, Alice K.; Walford, Gary D; Ling, Frederick S.K.; Venditti, Ferdinand J.; Gold, Jeffrey; King, Spencer B.

In: JACC: Cardiovascular Interventions, Vol. 11, No. 5, 12.03.2018, p. 500-502.

Research output: Contribution to journalArticle

Hannan, EL, Samadashvili, Z, Cozzens, K, Berger, PB, Chikwe, J, Jacobs, AK, Walford, GD, Ling, FSK, Venditti, FJ, Gold, J & King, SB 2018, '2017 Versus 2012 Appropriate Use Criteria for Percutaneous Coronary Interventions: Impact on Appropriateness Ratings' JACC: Cardiovascular Interventions, vol. 11, no. 5, pp. 500-502. https://doi.org/10.1016/j.jcin.2018.01.235
Hannan, Edward L. ; Samadashvili, Zaza ; Cozzens, Kimberly ; Berger, Peter B. ; Chikwe, Joanna ; Jacobs, Alice K. ; Walford, Gary D ; Ling, Frederick S.K. ; Venditti, Ferdinand J. ; Gold, Jeffrey ; King, Spencer B. / 2017 Versus 2012 Appropriate Use Criteria for Percutaneous Coronary Interventions : Impact on Appropriateness Ratings. In: JACC: Cardiovascular Interventions. 2018 ; Vol. 11, No. 5. pp. 500-502.
@article{431281fbbae44761aac53eda870224d9,
title = "2017 Versus 2012 Appropriate Use Criteria for Percutaneous Coronary Interventions: Impact on Appropriateness Ratings",
abstract = "Objectives: The purpose of this study is to revisit cases rated as “inappropriate” in the 2012 appropriate use criteria (AUC) using the 2017 AUC. Background: AUC for coronary revascularization in patients with stable ischemic heart disease (SIHD) were released in January 2017. Earlier 2012 AUC identified a relatively high percentage of New York State patients for whom percutaneous coronary intervention (PCI) was rated as “inappropriate” versus optimal medical therapy alone. Methods: New York State's PCI registry was used to rate inappropriateness of patients undergoing PCI in 2014 using the 2012 and 2017 AUC, and to examine patient characteristics for patients rated differently. Results: A total of 911 of 9,261 (9.8{\%}) patients who underwent PCI in New York State in 2014 with SIHD without prior coronary artery bypass grafting were rated as “inappropriate” using the 2012 AUC, but only 171 (1.8{\%}) patients were rated as “rarely appropriate” (“inappropriate” in 2012 AUC terminology) using the 2017 AUC. A total of 26{\%} of all 8,407 patients undergoing PCI in New York State with 1- to 2-vessel SIHD were without high-risk findings on noninvasive testing and were either asymptomatic or without antianginal therapy. No current or past randomized controlled trials have focused on these patients. Conclusions: The percentage of 2014 New York State PCI patients with SIHD who are rated “rarely appropriate” has decreased substantially using 2017 AUC in comparison with the older 2012 AUC. However, for many low-risk patients undergoing the procedure, the relative benefits of optimal medical therapy with and without PCI are unknown. Randomized controlled trials are needed to study these groups.",
keywords = "AUC, coronary revascularization appropriateness, percutaneous coronary intervention, stable ischemic heart disease",
author = "Hannan, {Edward L.} and Zaza Samadashvili and Kimberly Cozzens and Berger, {Peter B.} and Joanna Chikwe and Jacobs, {Alice K.} and Walford, {Gary D} and Ling, {Frederick S.K.} and Venditti, {Ferdinand J.} and Jeffrey Gold and King, {Spencer B.}",
year = "2018",
month = "3",
day = "12",
doi = "10.1016/j.jcin.2018.01.235",
language = "English (US)",
volume = "11",
pages = "500--502",
journal = "JACC: Cardiovascular Interventions",
issn = "1936-8798",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - 2017 Versus 2012 Appropriate Use Criteria for Percutaneous Coronary Interventions

T2 - JACC: Cardiovascular Interventions

AU - Hannan, Edward L.

AU - Samadashvili, Zaza

AU - Cozzens, Kimberly

AU - Berger, Peter B.

AU - Chikwe, Joanna

AU - Jacobs, Alice K.

AU - Walford, Gary D

AU - Ling, Frederick S.K.

AU - Venditti, Ferdinand J.

AU - Gold, Jeffrey

AU - King, Spencer B.

PY - 2018/3/12

Y1 - 2018/3/12

N2 - Objectives: The purpose of this study is to revisit cases rated as “inappropriate” in the 2012 appropriate use criteria (AUC) using the 2017 AUC. Background: AUC for coronary revascularization in patients with stable ischemic heart disease (SIHD) were released in January 2017. Earlier 2012 AUC identified a relatively high percentage of New York State patients for whom percutaneous coronary intervention (PCI) was rated as “inappropriate” versus optimal medical therapy alone. Methods: New York State's PCI registry was used to rate inappropriateness of patients undergoing PCI in 2014 using the 2012 and 2017 AUC, and to examine patient characteristics for patients rated differently. Results: A total of 911 of 9,261 (9.8%) patients who underwent PCI in New York State in 2014 with SIHD without prior coronary artery bypass grafting were rated as “inappropriate” using the 2012 AUC, but only 171 (1.8%) patients were rated as “rarely appropriate” (“inappropriate” in 2012 AUC terminology) using the 2017 AUC. A total of 26% of all 8,407 patients undergoing PCI in New York State with 1- to 2-vessel SIHD were without high-risk findings on noninvasive testing and were either asymptomatic or without antianginal therapy. No current or past randomized controlled trials have focused on these patients. Conclusions: The percentage of 2014 New York State PCI patients with SIHD who are rated “rarely appropriate” has decreased substantially using 2017 AUC in comparison with the older 2012 AUC. However, for many low-risk patients undergoing the procedure, the relative benefits of optimal medical therapy with and without PCI are unknown. Randomized controlled trials are needed to study these groups.

AB - Objectives: The purpose of this study is to revisit cases rated as “inappropriate” in the 2012 appropriate use criteria (AUC) using the 2017 AUC. Background: AUC for coronary revascularization in patients with stable ischemic heart disease (SIHD) were released in January 2017. Earlier 2012 AUC identified a relatively high percentage of New York State patients for whom percutaneous coronary intervention (PCI) was rated as “inappropriate” versus optimal medical therapy alone. Methods: New York State's PCI registry was used to rate inappropriateness of patients undergoing PCI in 2014 using the 2012 and 2017 AUC, and to examine patient characteristics for patients rated differently. Results: A total of 911 of 9,261 (9.8%) patients who underwent PCI in New York State in 2014 with SIHD without prior coronary artery bypass grafting were rated as “inappropriate” using the 2012 AUC, but only 171 (1.8%) patients were rated as “rarely appropriate” (“inappropriate” in 2012 AUC terminology) using the 2017 AUC. A total of 26% of all 8,407 patients undergoing PCI in New York State with 1- to 2-vessel SIHD were without high-risk findings on noninvasive testing and were either asymptomatic or without antianginal therapy. No current or past randomized controlled trials have focused on these patients. Conclusions: The percentage of 2014 New York State PCI patients with SIHD who are rated “rarely appropriate” has decreased substantially using 2017 AUC in comparison with the older 2012 AUC. However, for many low-risk patients undergoing the procedure, the relative benefits of optimal medical therapy with and without PCI are unknown. Randomized controlled trials are needed to study these groups.

KW - AUC

KW - coronary revascularization appropriateness

KW - percutaneous coronary intervention

KW - stable ischemic heart disease

UR - http://www.scopus.com/inward/record.url?scp=85042804071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042804071&partnerID=8YFLogxK

U2 - 10.1016/j.jcin.2018.01.235

DO - 10.1016/j.jcin.2018.01.235

M3 - Article

VL - 11

SP - 500

EP - 502

JO - JACC: Cardiovascular Interventions

JF - JACC: Cardiovascular Interventions

SN - 1936-8798

IS - 5

ER -